Kalopanaxsaponin B - Compound Card

Kalopanaxsaponin B

Select a section from the left sidebar

Kalopanaxsaponin B

Structure
Zoomed Structure
  • Family: Araliaceae
  • Kingdom: Plantae
  • Class: Saponin
    • Subclass: Oleanane-Type Saponin
Canonical Smiles OCC1O[C@@](O)(OCC2O[C@@](O)(OC(=O)[C@@H]3CC(C)(C)C[C@@H]4C3CC[C@@]3(C4=CCC4[C@@]3(C)CCC3[C@]4(C)CC[C@@H]([C@@]3(C)CO)OC3(O[C@H](C)[C@H]([C@@H]([C@@H]3O)O)O)C3OC[C@@H]([C@H]([C@H]3O)O)O)C)[C@H](C([C@@H]2O)O)O)[C@H](C([C@@H]1OC1O[C@H](C)[C@H]([C@@H]([C@@H]1O)O)O)O)O
InChI InChI=1S/C59H96O28/c1-23-35(63)39(67)43(71)51(81-23)82-45-30(19-60)84-58(77,48(75)44(45)72)80-21-31-38(66)41(69)47(74)59(78,85-31)87-50(76)27-18-52(3,4)17-26-25(27)11-15-55(7)28(26)9-10-33-53(5)14-13-34(54(6,22-61)32(53)12-16-56(33,55)8)86-57(46(73)40(68)36(64)24(2)83-57)49-42(70)37(65)29(62)20-79-49/h9,23-27,29-49,51,60-75,77-78H,10-22H2,1-8H3/t23-,24-,25?,26-,27-,29+,30?,31?,32?,33?,34+,35-,36-,37-,38-,39+,40+,41?,42-,43+,44?,45-,46+,47+,48+,49?,51?,53+,54+,55-,56-,57?,58+,59-/m1/s1
InChIKey VSGWOTCNBLIVAT-OSJHJRNKSA-N
Formula C59H96O28
HBA 28
HBD 18
MW 1253.39
Rotatable Bonds 12
TPSA 464.28
LogP -4.66
Number Rings 10
Number Aromatic Rings 0
Heavy Atom Count 87
Formal Charge 0
Fraction CSP3 0.95
Exact Mass 1252.61
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Oreopanax guatemalensis Araliaceae Plantae 2951918

Showing of synonyms

  • Meleka FR, Miyase T, et al. (2002). Triterpenoid saponins from Oreopanax guatemalensis. Phytochemistry,2002,60(2),185-195. [View] [PubMed]
CPRiL: 106600
Structure

SMILES: O1CCCCC1OC2CCC(OC2)OCC3CCCC(O3)OC(=O)C4CCCC5C4CCC(C5=6)C7C(CC6)C8C(CC7)CC(CC8)OC9(CCCCO9)C1CCCCO1

Level: 5

Mol. Weight: 825.14 g/mol

Structure

SMILES: O1CCCCC1OC2CCC(OC2)OCC3CCCC(O3)OC(=O)C4CCCC5C4CCC(C5=6)C7C(CC6)C8C(CC7)CC(CC8)OC9CCCCO9

Level: 4

Mol. Weight: 741.02 g/mol

Structure

SMILES: O1CCCCC1OCC2CCCC(O2)OC(=O)C3CCCC4C3CCC(C4=5)C6C(CC5)C7C(CC6)CC(CC7)OC8(CCCCO8)C9CCCCO9

Level: 4

Mol. Weight: 725.02 g/mol

Structure

SMILES: O1CCCCC1OCC2CCCC(O2)OC(=O)C3CCCC4C3CCC(C4=5)C6C(CC5)C7C(CC6)CC(CC7)OC8CCCCO8

Level: 3

Mol. Weight: 640.9 g/mol

Structure

SMILES: C1CCCC(CC2)C1C(CC3)C2C(C=34)CCC5C4CCCC5C(=O)OC(O6)CCCC6COC(OC7)CCC7OC8CCCCO8

Level: 3

Mol. Weight: 640.9 g/mol

Structure

SMILES: O1CCCCC1OC(=O)C2CCCC3C2CCC(C3=4)C5C(CC4)C6C(CC5)CC(CC6)OC7(CCCCO7)C8CCCCO8

Level: 3

Mol. Weight: 610.88 g/mol

Structure

SMILES: O1CCCCC1OCC2CCCC(O2)OC(=O)C3CCCC4C3CCC(C4=5)C6C(CC5)C7C(CC6)CCCC7

Level: 2

Mol. Weight: 540.79 g/mol

Structure

SMILES: O1CCCCC1OC(=O)C2CCCC3C2CCC(C3=4)C5C(CC4)C6C(CC5)CC(CC6)OC7CCCCO7

Level: 2

Mol. Weight: 526.76 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC6(CCCCO6)C7CCCCO7

Level: 2

Mol. Weight: 482.75 g/mol

Structure

SMILES: O1CCCCC1COC(OC2)CCC2OC3CCCCO3

Level: 2

Mol. Weight: 300.4 g/mol

Structure

SMILES: O1CCCCC1OC(=O)C2CCCC3C2CCC(C3=4)C5C(CC4)C6C(CC5)CCCC6

Level: 1

Mol. Weight: 426.64 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC6CCCCO6

Level: 1

Mol. Weight: 398.63 g/mol

Structure

SMILES: O1CCCCC1COC2CCCCO2

Level: 1

Mol. Weight: 200.28 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 186.25 g/mol

Structure

SMILES: O1CCCCC1C2CCCCO2

Level: 1

Mol. Weight: 170.25 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CCCC5

Level: 0

Mol. Weight: 298.51 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 86.13 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.62
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
10471645864.26
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
1368521162804.94

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.6
Plasma Protein Binding
41.86
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
1.26
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-31828708669.93
Biodegradation
Toxic
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-12995.95
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
4.05
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-2483799965315156.0
Rat (Acute)
4.48
Rat (Chronic Oral)
5327532.1
Fathead Minnow
3135265999855.71
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Toxic
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
279358648022795.1
Hydration Free Energy
-2.92
Log(D) at pH=7.4
-155295525.25
Log(P)
-18079.13
Log S
-1.56
Log(Vapor Pressure)
-9199138112899.17
Melting Point
-2791739.35
pKa Acid
-67030220006.42
pKa Basic
-539256118.16

No predicted protein targets found for this compound.

Download SDF